Seasoned investor and operator focused on growth-stage technology and healthcare opportunities, known for sourcing cross-border deals, driving operational improvements, and executing liquidity events. Paul Cohen brings experience across private equity, venture capital and operating roles, advising management teams on commercial strategy, go-to-market scaling and capital structure. Regular board director and active portfolio manager, prioritizes data-driven KPIs, margin expansion and disciplined M&A to create enterprise value for institutional investors.
Seasoned investor and operator focused on growth-stage technology and healthcare opportunities, known for sourcing cross-border deals, driving operational improvements, and executing liquidity events. Paul Cohen brings experience across private equity, venture capital and operating roles, advising management teams on commercial strategy, go-to-market scaling and capital structure. Regular board director and active portfolio manager, prioritizes data-driven KPIs, margin expansion and disciplined M&A to create enterprise value for institutional investors.
Focuses on growth-stage technology and healthcare companies, deploying capital with a hands-on, operationally driven approach that prioritizes data‑driven KPIs, margin expansion and scalable go‑to‑market playbooks. Prefers cross‑border and complex capital structures where disciplined M&A and active board involvement accelerate exits. Time horizon is growth-to-liquidity, balancing aggressive scaling with staged capital tranches, clear operational milestones and downside protection through conservative covenants and portfolio diversification.
Focuses on growth-stage technology and healthcare companies, deploying capital with a hands-on, operationally driven approach that prioritizes data‑driven KPIs, margin expansion and scalable go‑to‑market playbooks. Prefers cross‑border and complex capital structures where disciplined M&A and active board involvement accelerate exits. Time horizon is growth-to-liquidity, balancing aggressive scaling with staged capital tranches, clear operational milestones and downside protection through conservative covenants and portfolio diversification.
| Trades 221 | Longs Won 141/221 63% | Profit Factor 29.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2.83M |
| Average Win $422,917.23 | Best Trade (Jul 16) $41.88M | Sharpe Ratio -11.35 |
| Average Loss -$25,150.56 | Worst Trade (Mar 31) -$414,750.71 | Z-Score 4.88 (100%) |
| Commissions $0 | Avg. Trade Length 11m 2w | Expectancy $260,720.74 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 7,813 | 7,031 | 6,250 | 5,469 | 4,688 | 3,906 | 3,125 | 2,344 | 1,563 | 781 |